Veteran private equity investor with multi-decade experience focused on growth and buyout transactions across healthcare, technology and industrials. Benjamin S. Smith has led deal sourcing, due diligence and portfolio company operations, emphasizing EBITDA expansion and strategic M&A. Known for fundraising with institutional limited partners and for board-level oversight, he combines operational leadership with capital markets fluency to drive exits via trade sales and IPOs. Regularly advises management teams on scaling, governance and value creation.
Veteran private equity investor with multi-decade experience focused on growth and buyout transactions across healthcare, technology and industrials. Benjamin S. Smith has led deal sourcing, due diligence and portfolio company operations, emphasizing EBITDA expansion and strategic M&A. Known for fundraising with institutional limited partners and for board-level oversight, he combines operational leadership with capital markets fluency to drive exits via trade sales and IPOs. Regularly advises management teams on scaling, governance and value creation.
Seasoned private equity investor focused on control and growth buyouts across healthcare, technology and industrials, deploying capital to drive EBITDA expansion via hands-on operational improvement and strategic M&A. Investment decisions prioritize durable competitive advantages, scalable business models and clear exit pathways via trade sale or IPO. Capital allocation is control-oriented with a mid-to-long term horizon, active board governance, disciplined underwriting and risk mitigation through operational de-risking and diversified sector exposure, supported by institutional LP relationships and capital markets fluency.
Seasoned private equity investor focused on control and growth buyouts across healthcare, technology and industrials, deploying capital to drive EBITDA expansion via hands-on operational improvement and strategic M&A. Investment decisions prioritize durable competitive advantages, scalable business models and clear exit pathways via trade sale or IPO. Capital allocation is control-oriented with a mid-to-long term horizon, active board governance, disciplined underwriting and risk mitigation through operational de-risking and diversified sector exposure, supported by institutional LP relationships and capital markets fluency.
| Trades 444 | Longs Won 278/444 62% | Profit Factor 2.47 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $120,263.11 |
| Average Win $50,268.55 | Best Trade (Aug 11) $919,372.17 | Sharpe Ratio -9.5 |
| Average Loss -$34,134.44 | Worst Trade (Aug 02) -$844,260.99 | Z-Score 1.38 (83.33%) |
| Commissions $0 | Avg. Trade Length 11m 2w | Expectancy $18,712.48 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,731 | 3,358 | 2,985 | 2,612 | 2,239 | 1,866 | 1,493 | 1,119 | 746 | 373 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 13,293 | $3.24M | $4.11M | - | $862,329.78 | 26.58% | -7.354% |
AFB AllianceBernstein National Municipal Income Fund | 18,203 | $197,867 | $198,048.64 | - | $181.64 | 0.09% | -0.275% |
AMGN Amgen Inc. | 661 | $216,352 | $254,590.76 | - | $38,238.76 | 17.67% | -0.64% |
AMZN Amazon.com Inc | 7,097 | $1.55M | $1.93M | - | $382,048.97 | 24.72% | +15.321% |
ARCC Ares Capital Corporation | 349,766 | $7.49M | $6.56M | - | -$932,231.88 | -12.44% | -0.372% |
ASG Liberty All-Star Growth Fund, Inc. | 40,227 | $227,285.95 | $206,766.78 | - | -$20,519.17 | -9.03% | +0.784% |
ASGI abrdn Global Infrastructure Fund | 56,489 | $990,237.57 | $1.35M | - | $359,849.53 | 36.34% | +0.336% |
AWF AllianceBernstein Global High Income Fund Inc. | 386,580 | $4.15M | $3.9M | - | -$247,476.57 | -5.97% | -0.198% |
BGY BlackRock Enhanced International Dividend Trust | 478,458 | $2.54M | $2.77M | - | $224,852.82 | 8.85% | +0.522% |
BLW BlackRock Limited Duration Income Trust | 53,354 | $752,497.67 | $669,059.16 | - | -$83,438.51 | -11.09% | -0.159% |
BME BlackRock Health Sciences Opportunities Portfolio | 16,179 | $622,281.81 | $703,624.71 | - | $81,342.9 | 13.07% | -0.092% |
BRK-B Berkshire Hathaway Inc. | 15,920 | $7.42M | $8.14M | - | $724,784.23 | 9.77% | +0.365% |
BTZ BlackRock Credit Allocation Income Trust | 273,343 | $2.86M | $2.73M | - | -$133,976.39 | -4.69% | -0.499% |
BUI BlackRock Utilities, Infrastructure & Power Opportunities Trust | 52,521 | $1.24M | $1.43M | - | $192,621.06 | 15.51% | -0.292% |
CSQ Calamos Strategic Total Return Fund | 226,606 | $4.01M | $4.56M | - | $555,568.15 | 13.86% | +0.7% |
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc. | 93,742 | $1.87M | $1.95M | - | $75,003.75 | 4% | -0.336% |
DHC Diversified Healthcare Trust | 22,293 | $51,273.99 | $198,407.7 | - | $147,133.71 | 286.96% | -0.78% |
DIA SPDR Dow Jones Industrial Average ETF Trust | 1,075 | $561,569 | $563,644.01 | - | $2,075.01 | 0.37% | +0.539% |
DNP DNP Select Income Fund Inc. | 396,153 | $3.5M | $4.26M | - | $758,030.6 | 21.65% | -1.737% |
DOC Healthpeak Properties, Inc. | 27,243 | $552,230.72 | $594,714.69 | - | $42,483.97 | 7.69% | -1.043% |